Transcription of 797 PHARMACEUTICAL COMPOUNDING—STERILE …
{{id}} {{{paragraph}}}
Example: confidence
797 PHARMACEUTICAL COMPOUNDING—STERILE …
<797> PHARMACEUTICAL Compounding sterile Preparations Type of Posting Revision Bulletin Posting Date 22 Nov 2019. Official Date 01 Dec 2019. Expert Committee Compounding Reason for Revision Compliance Postponement In accordance with the Rules and Procedures of the 2015 2020 Council of Experts, USP is postponing the official date of PHARMACEUTICAL Compounding sterile Preparations <797>. After publication of the revised <797> on June 1, 2019, USP received appeals on certain provisions of the chapter. In accordance with USP's Bylaws, the responsible Expert Committees worked with a sense of urgency to consider the information raised in the appeals and issued decisions on the appeals. As part of the formal USP appeals process, stakeholders who submitted appeals to the compounding chapters had the opportunity to request further review by an appointed Panel, and USP has received three (3) such requests on <797>.
Nov 22, 2019 · This chapter describes the minimum standards to be followed when preparing compounded sterile human and animal drugs [compounded sterile preparations (CSPs)]. Sterile compounding is defined as combining, admixing, diluting, pooling, reconstituting, repackaging, or otherwise altering a drug or bulk drug substance to create a sterile medication.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: